Navigation Links
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Date:3/10/2011

d at an upcoming medical meeting.

"Bringing new and innovative cancer therapies to patients can be incredibly challenging, especially in difficult-to-treat cancers such as second-line non-small cell lung cancer," said Debasish Roychowdhury, SVP and Head of Global Oncology Division, sanofi-aventis.  "Our Phase III trials of aflibercept in metastatic colorectal cancer and hormone-refractory metastatic prostate cancer are underway to determine the clinical potential of aflibercept for patients with these advanced cancers."

About the VITAL Phase III StudyThe VITAL study was a multinational, randomized, double-blind trial comparing aflibercept versus placebo in combination with docetaxel patients with locally advanced or metastatic non-squamous NSCLC who have failed one platinum-based therapy.  The study enrolled 913 patients who were randomized to receive intravenous (IV) docetaxel 75 mg/m2 plus either IV placebo or IV aflibercept 6 mg/kg every three weeks until disease progression, unacceptable toxicity, patient's refusal or further treatment.  The primary objective of the study was to demonstrate improvement in overall survival with the combination of aflibercept and docetaxel compared with placebo and docetaxel.

About the Aflibercept Clinical Development ProgramSanofi-aventis Oncology and Regeneron are collaborating on a broad oncology development program, combining the investigational agent aflibercept with common chemotherapy regimens in the treatment of patients with advanced cancers.  In addition to VITAL, the program includes two Phase III trials and one Phase II trial, all of which are fully enrolled:

  • VELOUR: Second-line treatment for metastatic colorectal cancer in combination with 5-fluorouracil, leucovorin and irinotecan (FOLFIRI) (Phase III).  Final results are anticipated during the first half of 2011.

  • VENICE: First-line treatment for hormone-refractory metastatic prostate cancer in
    '/>"/>

  • SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
    2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
    3. Sanofi-aventis Stands Behind the Safety of Lantus(R)
    4. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
    5. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
    6. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
    7. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
    8. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
    9. Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
    10. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
    11. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)...  - MediaLINC unlocks ... Lincor announced general availability of MediaLINC - ... range of education, entertainment and clinical content direct to ... , " Lincor has already ... engagement to bedside smart devices, " comments Dan ...
    (Date:8/21/2014)... Aug. 21, 2014  Aptuit LLC announces that ... Indiana , has enhanced its capabilities in ... small and large molecules, including biologic drugs, metabolites, ... maXisPlus Q-TOF mass spectrometer. In making ... Aptuit, said, "The expanded large molecule capability enhances ...
    (Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
    Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
    ... Demonstrates Commitment to Patient Safety; Approved Sites Eligible to Advertise through ... , , ... July 28 The National Association of Boards of Pharmacy ... Kerr Drug as the first online pharmacy services to be approved ...
    ... , BOCA RATON, Fla. , July 28 ... with Tris Pharma, the company will market Methylphenidate Solution, ... Inc., under an Abbreviated New Drug Application (ANDA).  Under ... manufactured by Tris Pharma, and marketed and distributed by ...
    Cached Medicine Technology:NABP Grants First 'Approved e-Advertiser' Status to Pharmahelper.com, QC Supply, and Kerr Drug 2NABP Grants First 'Approved e-Advertiser' Status to Pharmahelper.com, QC Supply, and Kerr Drug 3Breckenridge Pharmaceutical to Market Methylphenidate Oral Solution Through Agreement With Tris Pharma (Monmouth Junction, NJ) 2
    (Date:8/22/2014)... (PRWEB) August 23, 2014 Recently, iFitDress.com, ... its new collection of discounted wedding gowns . ... announced that all these new products are provided with ... are very happy to unveil the new wedding gowns. ... special occasion gowns for ladies to choose from. What’s ...
    (Date:8/22/2014)... The LSU Health New Orleans School of ... Traineeship grant to increase access to advanced nursing ... under-represented groups, as well as veterans. The Health ... of Health and Human Services awarded the two-year ... the grant,s project director., The Advanced Education Nursing ...
    (Date:8/22/2014)... Natural Clear Vision , a how-to guide ... vision from legally blind to perfect 20/20 vision has caught ... , “There is a huge portion of the population today ... most people just think that’s the way it will always ... be pretty risky at times,” reports Michaels. “This program is ...
    (Date:8/22/2014)... somatic mutation at amino acid 918 in the RET ... cell lung cancer (SCLC) tumors and enforced expression of ... signaling and cell growth. , SCLC is a highly ... lung cancers and is strongly associated with tobacco smoking. ... examined for genomic alterations and targeted therapies are approved ...
    (Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
    Breaking Medicine News(10 mins):Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2
    ... Delhi went on mass casual leave Monday, joining ... the sufferings of patients. ,The majority of ... University College of Medical Sciences (UCMS) and Safdarjung ... resentment against the government decision to implement 27 ...
    ... zero alcohol quotient is highly conducive for the cognitive ... research has suggested//. Infact, even moderated alcohol intake during ... unborn child. ,The study conducted by the University ... Washington, has shown that those children, whose mothers had ...
    ... over 3500 and an incalculable number of people injured after ... cope with the injured and the dead. ,The quake ... city of Yogyakarta which is near the southern coast of ... left the city in shambles, cutting off communications and road ...
    ... American study conducted by Arthur Krigsman, of New York ... links to autism//. MMR inoculation is given to young ... But recently there have been claims that the vaccine ... fall in the MMR vaccine uptake rate which has ...
    ... the world and it has drastically affected the sales of chicken ... for chicken// and the sales are slowly picking up in the ... stage. ,Mohamed Al Shafei, director of the General Union ... great deal in the past with a large number of chickens ...
    ... very similar to the technology in the United States, and ... for filling up nursing vacancies. With India also being rated ... are realizing their dream of seeking greener pastures. , ... from India who will be joining the hospital during this ...
    Cached Medicine News:Health News:Mass Leave By Doctors Leaves Patients Helpless 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2
    ... replace the carpal scaphoid bone. The implant has ... under a shelf formed in the carpal trapezium ... the proximal hole for suture fixation. These temporarily ... period until a firm capsuloligamentous system has formed ...
    ... has the same anatomical configuration as the ... to provide for stability. The implant has ... use in suture fixation through the scaphoid ... while a capsuloligamentous system forms around the ...
    ... for four corner fusion of the capitate, ... hand. The plate is intended for use ... of function due to SLAC and SNAC ... rheumatoid arthritis. When combined with the specially ...
    The 3.0 mm Cannulated Screw can be used with or without threaded washer. Uses 1.1 mm threaded or non-threaded guide wire. , ,The Threaded Washer provides a recessed internal buttress which allows the...
    Medicine Products: